- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03049605
Effects of Electromagnetic Therapy Versus Laser Therapy on Peripheral Diabetic Neuropathy
February 9, 2017 updated by: Imam Abdulrahman Bin Faisal University
Effects of Electromagnetic Therapy Versus Laser Therapy on Peripheral Neuropathy in Diabetic Patients
This study are to:
- Evaluate effect of magnetic therapy on peripheral neuropathy in diabetic patients.
- Evaluate effect of laser therapy on peripheral neuropathy in diabetic patients.
- Compare effects of magnetic therapy with that of laser therapy on peripheral neuropathy in diabetic patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sixty- five male and female diabetic patients with peripheral neuropathy will be selected to participate in this study.
They will be equally divided into two groups Group-I: Twenty five patient with diabetic peripheral neuropathy will be exposed to low intensity pulsed magnetic therapy Group-II: Twenty five patients with diabetic peripheral neuropathy will be exposed for 24 treatment sessions of laser therapy Group-III 15 patient received only medical treatment
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Phase 2
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All diabetic patients with peripheral neuropathy will be selected to participate in this study.
- Their age ranges from 35 to 65 years old.
- All patients under medical control (optimal blood glucose). such as analgesic medications (e.g. opiates, anti-depressants, anticonvulsants and diabetic drugs to control blood glucose).
Exclusion Criteria:
- Patients have DPN due to other causes than diabetes
- Ulcers in either foot
- Lack of blood sugar control
- Other nervous system impairments
- Visual problems
- Unstable medical conditions
- Pregnancy
- Metallic implants
- Alcohol or drug abuse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Magnetic Therapy
Twenty five patient were exposed to low intensity pulsed magnetic therapy with a frequency of 200 Hertz and intensity of 50 Gauss for 30 minutes / session for 2 times per week for 3 months .
|
low intensity pulsed magnetic therapy with a frequency of 200 Hertz and intensity of 50 Gauss .
Magnetic device will be applied on each patient from a comfortable supine lying position.
After the connection of appliance to electrical supply, the actions of PEMF will be directed and adjusted over lumbar spine, hip regions and calf muscles of both lower limbs.
|
|
Experimental: Laser Therapy
Twenty five patients were treated with 24 sessions of laser therapy at a rate of two sessions / week for three months.
Each patient will be exposed to Helium neon infrared laser (850 nano-meter continuous wave mode from a comfortable prone lying position.
|
laser therapy of Helium neon infrared laser (850 nano-meter) was used in continuous wave mode from a comfortable prone lying position on the whole plantar surface of the foot and the lumbo-sacral area by four points, and two points laterally to the spine.
|
|
Experimental: Medical therapy
Fifteen patients were received only medical treatment .
|
Fifteen patients with diabetic peripheral neuropathy were treated with antidiabtic drugs and lyrica 150 milligram daily
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor and sensory conduction velocity of the lower limb nerves
Time Frame: 30-45 minutes
|
it is used for measuring motor and sensory conduction velocity: For this purpose nerve conduction studies (NCSs) will be performed for all patients including evaluation of bilateral peroneal and tibia motor nerves and sural sensory nerves (Asad 2009).
Patients with NCV from 33-48m /sec will be recruited in this study (Pericz and Cvetkovic 2006 , and Graak 2009).
All measurement will be done at stander room temperature of 25 c.
The skin temperature of the leg was maintained at 37ᴄ. (Asad et al 2009).
|
30-45 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Enas F. Alananey, PhD, Associate professor university of Dammam
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 25, 2014
Primary Completion (Actual)
January 1, 2015
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
February 8, 2017
First Submitted That Met QC Criteria
February 9, 2017
First Posted (Actual)
February 10, 2017
Study Record Updates
Last Update Posted (Actual)
February 10, 2017
Last Update Submitted That Met QC Criteria
February 9, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 2014171
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
The individuals date not shared but the final results comments will appear only
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
Clinical Trials on Magnetic therapy
-
pico-tesla Magnetic Therapies, LLCCompletedFibromyalgia
-
Wave NeuroscienceCompletedStress Disorders, Post-TraumaticUnited States
-
Charles University, Czech RepublicRecruitingMajor Depressive Disorder (MDD) | Treatment Resistant Depression (TRD)Czechia
-
Shanghai Children's Medical CenterRecruiting
-
Wave NeuroscienceCompletedAutism Spectrum DisorderUnited States
-
University of California, San FranciscoRecruiting
-
VA Office of Research and DevelopmentNational Center for PTSDRecruiting
-
Legion Veterans Village Research FoundationNot yet recruitingChronic Pain | Post-traumatic Stress Disorder (PTSD)Canada
-
Medical University of South CarolinaNot yet recruiting
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)RecruitingMood Disorders | Schizophrenia | Obsessive-Compulsive Disorder | Generalized Anxiety Disorder | Major Depressive Disorder | Depression, Anxiety | Psychiatric Disorder | Mental DisorderUnited States